Insmed Inc.
Key Metrics
Market Snapshot
About
Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious rare diseases and unmet medical needs. The company's lead product is approved for treating certain mycobacterial lung infections in adults with limited treatment options. Insmed's pipeline includes therapies targeting rare pulmonary diseases and other conditions affecting small patient populations. The company combines proprietary drug delivery technologies with novel therapeutic approaches to address diseases where current treatments are inadequate or nonexistent.